Skip to content
healthcare.dev

Neulasta

NDC 55513-099, pegfilgrastim, solution, from Amgen, Inc.

Product NDC
55513-099
Status
Listed
Labeler
Amgen, Inc
Dosage form
SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125031
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55513-099 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PEGFILGRASTIM4 mg/.4mL

Pharmacologic classes

Granulocyte Colony-Stimulating Factor [CS]; Increased Myeloid Cell Production [PE]; Leukocyte Growth Factor [EPC]

Package NDCNDC-11Package
55513-099-01555130099011 VIAL in 1 CARTON (55513-099-01) / .4 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/fdfe5d72-6b80-435a-afa4-c5d74dd852ce
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=55513-099

Use it

Look up 55513-099 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55513-099 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55513-099. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.